| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 41 |
| 1 | BISOPROLOL FUMARATE | 32 |
| 2 | METFORMIN | 26 |
| 3 | METFORMIN ER 500 MG | 26 |
| 4 | METFORMIN ER 750 MG | 26 |
| 5 | APIXABAN | 25 |
| 6 | CARVEDILOL | 23 |
| 7 | RAMIPRIL | 22 |
| 8 | DAPAGLIFLOZIN | 21 |
| 9 | EPLERENONE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FELBAMATE | 6 | 0.0034 |
| 1 | RUFINAMIDE | 6 | 0.0023 |
| 2 | EPLERENONE | 21 | 0.0016 |
| 3 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 4 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 2 | 0.0014 |
| 5 | SAXAGLIPTIN | 2 | 0.0014 |
| 6 | PINDOLOL | 1 | 0.0012 |
| 7 | PERINDOPRIL ERBUMINE | 7 | 0.0012 |
| 8 | DIFLUNISAL | 1 | 0.0012 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 48 |
| 1 | Loop Diuretic [EPC] | 42 |
| 2 | Aldosterone Antagonist [EPC] | 30 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 4 | beta-Adrenergic Blocker [EPC] | 28 |
| 5 | Corticosteroid [EPC] | 27 |
| 6 | Factor Xa Inhibitor [EPC] | 26 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 24 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 24 |
| 9 | alpha-Adrenergic Blocker [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carnitine Analog [EPC] | 4 | 0.0011 |
| 1 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 8 | 0.0010 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 8 | 0.0006 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 4 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 5 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 6 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 24 | 0.0002 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 9 | Ergot Derivative [EPC] | 1 | 0.0002 |